May 24, 2025 01:33 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'India has every right to defend itself against terrorism': Germany on Operation Sindoor | Trump administration bans Harvard University from enrolling international students | ED accuses Sonia Gandhi, Rahul Gandhi of cheating, money laundering in National Herald case | 'Russia, Ukraine will immediately start negotiations for ceasefire': Donald Trump after call with Putin | 'Jill and I have learned that we are strongest in the broken places': Joe Biden on cancer diagnosis | Rahul Gandhi targets Jaishankar over Op. Sindoor again, BJP says LoP speaking Pak language | Supreme Court orders SIT probe into Madhya Pradesh minister's remarks on Colonel Sofiya Qureshi | Bengaluru: Woman killed after wall collapses on her after heavy rainfall | Pak forces targeted Golden Temple after India conducted Operation Sindoor: Army | YouTuber Jyoti Malhotra, arrested for 'espionage', travelled to Pakistan ahead of Pahalgam attack
Covid-19 vaccines
Image Credit: Pixabay

Serum Institute, Bharat Biotech get DCGI approval for emergency use of Covid-19 vaccines

| @indiablooms | Jan 03, 2021, at 05:58 pm

New Delhi/IBNS: Two Covid-19 vaccine candidates-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-on Sunday received the approval of the Drugs Controller General of India (DCGI) for emergency use in India.

Drug Controller General of India VG Somani said both firms submitted data based on their trial runs and both have been granted permission for "restricted use".

"We'll never approve anything if there is slightest of safety concern. The vaccines are 100 per cent safe," Somani said at a media briefing.

Sharing the news, Prime Minister Narendra Modi tweeted: "It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion."

Reacting to the approval, Adar Poonawalla, the chief executive of the Pune-based vaccine manufacturer, said the risks taken with stockpiling the vaccine, have finally paid off.

The vaccines received the approval after they were cleared by a government-appointed panel on Jan 1 and 2.

The Serum Institute of India (SII) has made the vaccine Covishield developed by Oxford University and pharma major AstraZeneca, while Bharat Biotech has partnered with the Indian Council of Medical Research (ICMR) for its indigenous Covaxin.
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu